Skip to main content

Associations between anticoagulation therapy and risks of mortality and readmission among patients with heart failure and atrial fibrillation.

Publication ,  Journal Article
Hernandez, AF; Liang, L; Fonarow, GC; Hammill, BG; Hammill, SC; Heidenreich, PA; Masoudi, FA; Qualls, LG; Al-Khatib, SM; Piccini, JP; Curtis, LH
Published in: Circ Cardiovasc Qual Outcomes
September 2014

BACKGROUND: Patients with heart failure and atrial fibrillation are at higher risk of thromboembolic events than patients with heart failure alone. Yet, the use of anticoagulation therapy varies in clinical practice, especially among older patients, for whom its effectiveness is poorly understood. METHODS AND RESULTS: Using clinical registry data linked to Medicare claims from 2005 to 2011, we examined outcomes of older patients hospitalized with heart failure and atrial fibrillation who newly initiated anticoagulation therapy at discharge. We used Cox proportional hazards models and inverse probability-weighted treatment estimates to adjust for selection bias. Main outcomes were mortality and readmission at 1 and 3 years. Among 5105 patients in 195 hospitals, 1623 (31.8%) started anticoagulation therapy at discharge. Treated patients had lower unadjusted rates of all-cause mortality (26.4% versus 42.8%; P<0.001) and all-cause readmission (58.4% versus 63.7%; P<0.001) at 1 year. After inverse weighting for the probability of treatment and adjustment for other discharge medications, anticoagulation therapy was associated with significantly lower 1-year mortality (hazard ratio, 0.70; 99% confidence interval, 0.59-0.82), but there was no statistically significant difference in the risk of all-cause readmission (hazard ratio, 0.89; 99% confidence interval, 0.78-1.01) or other readmission outcomes. Results were similar at 3 years. CONCLUSIONS: Initiation of anticoagulation therapy at hospital discharge was associated with improved mortality at 1 and 3 years but was not associated with improved cardiovascular readmission among older patients with heart failure and atrial fibrillation.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circ Cardiovasc Qual Outcomes

DOI

EISSN

1941-7705

Publication Date

September 2014

Volume

7

Issue

5

Start / End Page

670 / 679

Location

United States

Related Subject Headings

  • United States
  • Treatment Outcome
  • Survival Analysis
  • Patient Readmission
  • Outcome and Process Assessment, Health Care
  • Observer Variation
  • Male
  • Humans
  • Heart Failure
  • Follow-Up Studies
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hernandez, A. F., Liang, L., Fonarow, G. C., Hammill, B. G., Hammill, S. C., Heidenreich, P. A., … Curtis, L. H. (2014). Associations between anticoagulation therapy and risks of mortality and readmission among patients with heart failure and atrial fibrillation. Circ Cardiovasc Qual Outcomes, 7(5), 670–679. https://doi.org/10.1161/CIRCOUTCOMES.113.000632
Hernandez, Adrian F., Li Liang, Gregg C. Fonarow, Bradley G. Hammill, Stephen C. Hammill, Paul A. Heidenreich, Frederick A. Masoudi, et al. “Associations between anticoagulation therapy and risks of mortality and readmission among patients with heart failure and atrial fibrillation.Circ Cardiovasc Qual Outcomes 7, no. 5 (September 2014): 670–79. https://doi.org/10.1161/CIRCOUTCOMES.113.000632.
Hernandez AF, Liang L, Fonarow GC, Hammill BG, Hammill SC, Heidenreich PA, et al. Associations between anticoagulation therapy and risks of mortality and readmission among patients with heart failure and atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2014 Sep;7(5):670–9.
Hernandez, Adrian F., et al. “Associations between anticoagulation therapy and risks of mortality and readmission among patients with heart failure and atrial fibrillation.Circ Cardiovasc Qual Outcomes, vol. 7, no. 5, Sept. 2014, pp. 670–79. Pubmed, doi:10.1161/CIRCOUTCOMES.113.000632.
Hernandez AF, Liang L, Fonarow GC, Hammill BG, Hammill SC, Heidenreich PA, Masoudi FA, Qualls LG, Al-Khatib SM, Piccini JP, Curtis LH. Associations between anticoagulation therapy and risks of mortality and readmission among patients with heart failure and atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2014 Sep;7(5):670–679.

Published In

Circ Cardiovasc Qual Outcomes

DOI

EISSN

1941-7705

Publication Date

September 2014

Volume

7

Issue

5

Start / End Page

670 / 679

Location

United States

Related Subject Headings

  • United States
  • Treatment Outcome
  • Survival Analysis
  • Patient Readmission
  • Outcome and Process Assessment, Health Care
  • Observer Variation
  • Male
  • Humans
  • Heart Failure
  • Follow-Up Studies